Jon has been reporting on stock markets for over twenty-five years for audio text companies (remember them?!), newswires, and websites. He helped set up MarketEye News for ICV/Topic in the 1990’s before moving on to become a Markets reporter at AFX News. After over 10 years, which saw him rise to the dizzy heights of Markets Editor at AFX, the firm’s acquisition by Thomson Corp and subsequent takeover of Reuters, he moved on in 2012. Prior to Proactive Investors, he was News Editor for thisismoney.co.uk, the Mail Online’s financial website.
The Swiss bank's analysts said: “Three surprises drive our more cautious view: negative trends for JE UK brand perception, a re-acceleration of UK share loss, and worrying search trends in many markets"
The FTSE 100-listed firm said Atracsys' fusionTrack 500 optical tracking camera will be a core enabling technology for its multi-asset digital surgery and robotic ecosystem
“Our analysis leaves us comfortable that S&N has a sufficiently competitive portfolio in Orthopaedics (Reconstruction and Sports Medicine), with recent under-performance more likely reflective of weak commercial execution”
The US broker's analysts pointed out that Ocado’s valuation “now assumes an unequivocal commercial success of the OSP for its existing customers (and their 38 contracted sheds)”
Geremy Thomas, founder and chief executive officer of the medicinal cannabis and wellness cannabidiol (CBD) group said: "Sativa is delivering real revenues in a new and exciting sector"
Over the weekend The Guardian published an in-depth piece on the emerging treatments for erectile dysfunction (ED) with a significant focus on Futura's MED2005 product
The FTSE All-Share-listed firm said Paul Fry, its chief financial officer, will assume the role of CEO in an interim capacity, in addition to his current responsibilities
The firm said its working capital position is dependent on new funds being made available to it and anticipates that the investor will provide it with additional funds under the new facility